Acquiring Company
Transcarent
Acquired Company
Accolade
San FranciscoSeattleHealth CareHealthcareHealth CareMedicalDescription
Transcarent has successfully completed its acquisition of Accolade for approximately $621 million. The deal received all necessary shareholder and regulatory approvals. Accolade shareholders received $7.03 per share in cash, and the company will no longer trade on the Nasdaq. Transcarent aims to enhance its offerings by integrating Accolade's capabilities.
Quick answer
Transcarent is acquiring Accolade for $621 million, announced April 8, 2025. Transcarent is based in San Francisco, California, United States.
- How much did Transcarent pay for Accolade?
- The reported deal value is $621 million.
- What does Transcarent do?
- Transcarent makes it easy for people to access high-quality, affordable health and care.
- Where are Transcarent and Accolade based?
- Transcarent is based in San Francisco, California, United States. Accolade is based in Seattle, Washington, United States.
- Who are the decision-makers at Transcarent?
- Fundz holds 1 contact at Transcarent. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Basel Medical Group acquires Bethesda Medical (April 30, 2025)
- AbbVie to acquire Cerevel for $45 per share (April 15, 2025)
- Organon acquires Tofidence biosimilar rights (April 14, 2025)
- Globus Medical completes acquisition of Nevro Corp. (April 3, 2025)
- AbbVie acquires Cerevel Therapeutics for $45 per share (March 31, 2025)
- Concentra acquires Miami-Dade clinics from PHC and OMM (March 10, 2025)
Who to call at Transcarent, and when
When Transcarent changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Transcarent raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Transcarent, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Transcarent. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Transcarent makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Accolade?
Accolade was acquired by Transcarent, based in San Francisco. The deal was reported on April 12, 2025. Transcarent makes it easy for people to access high-quality, affordable health and care. Transcarent is privately held and operates in Health Care.
When did Transcarent acquire Accolade?
Transcarent's acquisition of Accolade was reported on April 12, 2025. Transcarent has successfully completed its acquisition of Accolade for approximately $621 million. The deal received all necessary shareholder and regulatory approvals. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Accolade do?
Accolade, Inc. is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences. It is privately held, operating in Healthcare, and is based in Seattle.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.